2-tert-butylcyclopent-2-en-1-one | 5682-67-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-tert-butylcyclopent-2-en-1-one
• 英文别名: 2-t.butylcyclopent-2-enone；2-tert.-Butyl-cyclopent-2-en-1-on；2-tert.-Butyl-3-oxo-cyclopenten；2-tert.-Butylcyclopent-2-enon；2-tert-Butyl-2-cyclopentenon
• CAS: 5682-67-7
• 化学式: C₉H₁₄O
• 分子量: 138.21
• InChiKey: NPMKABDIXZAVIK-UHFFFAOYSA-N

物化性质

• 沸点：
  76 °C(Press: 12 Torr)
• 密度：
  0.968±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-tert-butylcyclopent-2-en-1-one 在 N-溴代丁二酰亚胺(NBS) 、 过氧化苯甲酰 作用下， 以 四氯化碳 为溶剂， 生成 1-溴频哪酮
  参考文献：
  名称：

  tert-Butyl-substituted cyclopentadienones

  摘要：

  DOI：

  10.1021/ja01052a042
• 作为产物：
  描述：

  3-(叔丁基)环戊酮 以 甲酸 为溶剂， 生成 2-tert-butylcyclopent-2-en-1-one
  参考文献：
  名称：

  tert-Butyl-substituted cyclopentadienones

  摘要：

  DOI：

  10.1021/ja01052a042

文献信息

• <i>Lone</i>Selectivity of the Decatungstate-Sensitized Photooxidation of 1-Substituted Cycloalkenes
  作者：Michael Orfanopoulos、Ioannis N. Lykakis

  DOI：10.1055/s-2004-832803

  日期：——

  Decatungstate-sensitized oxidation of alkyl and phenyl substituted cycloalkenes in the presence of molecular oxygen shows a general preference for hydrogen abstraction on the congested side of the double bond.

  在分子氧存在下，带有烷基和苯基取代的环烯烃通过十钨酸盐敏化的氧化反应，表现出一贯偏好从双键拥挤侧进行氢抽取的行为。
• EXTRACELLULAR TARGETED DRUG CONJUGATES
  申请人：Hutchinson Charles R.

  公开号：US20110064752A1

  公开（公告）日：2011-03-17

  The present invention relates to, inter alia, extracellular drug conjugates (EDC) in which an antibody or other targeting agent (e.g. a targeting moiety) is linked to a drug through a linker (e.g. a non-cleavable linker). These conjugates are useful in the treatment of disease and/or as a tool in the evaluation of biological systems.

  本发明涉及细胞外药物结合物（EDC），其中抗体或其他靶向剂（例如靶向基团）通过连接剂（例如不可切割的连接剂）与药物连接。这些结合物在治疗疾病和/或作为评估生物系统的工具中很有用。
• Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
  申请人：——

  公开号：US20040242410A1

  公开（公告）日：2004-12-02

  The present invention relates to a transition metal complex represented by the formula (I): 1 wherein M represents a Group 4 transition metal; —Y— represents (a): —C(R 1 )(R 20 )-A-, (b): —C(R 1 )(R 20 )-A 1 (R 30 )—, (c): —C(R 1 )=A 1 -, or (d): —C(R 1 )=A 1 -A 2 -R 30 ; A represents a Group 16 element and A 1 and A 2 each represents a Group 15 element; R 1 to R 9 , R 20 , and R 30 are the same or different and each represents an optionally substituted hydrocarbon group, etc.; and X 1 and X 2 are the same or different and each represents a hydrogen atom, a halogen atom, an optionally substituted C 1-10 alkyl group, etc., and an intermediate product thereof, and a catalyst for olefin polymerization which comprises said transition metal complex as a component.

  本发明涉及一种由式(I)表示的过渡金属配合物：1其中M代表4族过渡金属；—Y—表示(a)：—C(R1)(R20)-A-，(b)：—C(R1)(R20)-A1(R30)—，(c)：—C(R1)=A1-，或(d)：—C(R1)=A1-A2-R30；A代表16族元素，A1和A2分别代表15族元素；R1至R9、R20和R30相同或不同，每个代表可选取代的碳氢基团等；X1和X2相同或不同，每个代表氢原子、卤原子、可选取代的C1-10烷基团等，以及其中间产物，以及包括所述过渡金属配合物作为组分的烯烃聚合催化剂。
• TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME
  申请人：HANAOKA Hidenori

  公开号：US20100048933A1

  公开（公告）日：2010-02-25

  The present invention relates to a transition metal complex represented by the formula (I): wherein M represents a Group 4 transition metal; —Y— represents (a): —C(R 1 )(R 20 )-A-, (b): —C(R 1 )(R 20 )-A 1 (R 30 )—, (c): —C(R 1 )=A 1 -, or (d): —C(R 1 )=A 1 -A 2 -R 30 ; A represents a Group 16 element and A 1 and A 2 each represents a Group 15 element; R 1 to R 9 , R 20 , and R 30 are the same or different and each represents an optionally substituted hydrocarbon group, etc.; and X 1 and X 2 are the same or different and each represents a hydrogen atom, a halogen atom, an optionally substituted C 1-10 alkyl group, etc., and an intermediate product thereof, and a catalyst for olefin polymerization which comprises said transition metal complex as a component.

  本发明涉及一种由式(I)表示的过渡金属配合物：其中M代表4族过渡金属；-Y-代表(a)：-C(R1)(R20)-A-，(b)：-C(R1)(R20)-A1(R30)-，(c)：-C(R1)=A1-，或(d)：-C(R1)=A1-A2-R30；A代表16族元素，A1和A2各代表15族元素；R1至R9、R20和R30相同或不同，每个代表一个可选取代的碳氢基团等；X1和X2相同或不同，每个代表氢原子、卤原子、可选取代的C1-10烷基团等；以及其中间体产品和以该过渡金属配合物为组分的烯烃聚合催化剂。
• GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
  申请人：Hutchinson Charles R.

  公开号：US20110319350A1

  公开（公告）日：2011-12-29

  The present invention provides glycoside compounds, methods of preparing such compounds, pharmaceutical compositions comprising such compounds, and a method for the treatment of hyperproliferative diseases using the same.

  本发明提供了一种糖苷化合物、制备这种化合物的方法、包含这种化合物的药物组合物以及使用它们治疗增生性疾病的方法。